Table 4 Coverage statistics for exome sequencing experiment.

From: Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product

Patient / Sample ID

Normal

Tumor

Vigil

Total read pairs (millions)

64.67

558.13

544.29

Aligned read pairs (millions)

63.71

548.35

533.76

On target bases (millions, before UMI)

6,233

53,178

51,925

On target bases (millions, after UMI)

4,480

34,039

34,038

Percentage duplicate reads

28%

36%

34%

Mean target coverage before UMI processing

171

1,459

1,424

Mean target coverage after UMI processing

123

934

934

Percentage loss in coverage

28.1%

36.2%

34.4%

% Target bases at 50X (pre-UMI)

98.4%

98.8%

98.8%

% Target bases at 100X (pre-UMI)

93.6%

98.7%

98.7%

% Target bases at 250X (pre-UMI)

6.8%

98.5%

98.5%

% Target bases at 500X (pre-UMI)

0.1%

97.3%

97.1%

% Target bases at 50X (post-UMI)

98.0%

98.7%

98.7%

% Target bases at 100X (post-UMI)

74.9%

98.6%

98.6%

% Target bases at 250X (post-UMI)

0.5%

97.9%

98.2%

% Target bases at 500X (post-UMI)

0.0%

88.6%

90.5%